FrancophonIA/ELRC3.0 huggingface dataset:
English: At the time of the initial recommendation, the CHMP had concerns about results from animal studies showing a higher occurrence of cancers after long-term exposure to the medicine and noted that a similar long-term cancer risk could not be excluded in humans, especially when considering that the way the medicine works in the body is unclear.
Danish: På tidspunktet for den oprindelige anbefaling var der i CHMP betænkelighed ved resultaterne af dyreundersøgelserne, der viste højere forekomst af kræft efter lang tids udsættelse for lægemidlet.
English: The CHMP noted that the effect of the medicine in preventing relapses was modest, and though its effect in slowing the worsening of disability was encouraging it still needed to be confirmed.
Danish: Selv om det havde nogen virkning ved at bremse udviklingen af invaliditet, manglede der stadig bekræftelse heraf.
English: What measures are being taken to ensure the safe and effective use of
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv
English: What is Fexeric and what is it used for?
Danish: Hvad er Fexeric, og hvad anvendes det til?
English: The maximum dose is 12 tablets per day.
Danish: Den maksimale dosis er 12 tabletter dagligt.
English: The full EPAR and risk management plan summary for Fexeric can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Danish: Den fuldstændige EPAR og resuméet af risikostyringsplanen for Fexeric findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Other information about Fexeric
Danish: Andre oplysninger om Fexeric
English: Serious side effects were uncommon and mainly affected the gut and stomach.
Danish: Alvorlige bivirkninger var ikke almindelige og berørte hovedsagelig tarm og mave.
English: This is a summary of the European public assessment report (EPAR) for Fexeric.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Fexeric.
English: The overall safety profile was considered acceptable and comparable to other phosphate binders.
Danish: Den overordnede sikkerhedsprofil blev anset for acceptabel og sammenlignelig med profilen af andre fosfatbindere.
English: A risk management plan has been developed to ensure that Fexeric is used as safely as possible.
Danish: Der er udarbejdet en risikostyringsplan for at sikre, at Fexeric anvendes så sikkert som muligt.
English: Fexeric is available as 1 g tablets.
Danish: Fexeric leveres som 1 g tabletter.
English: In the second study, 149 patients who were not on dialysis received either Fexeric or placebo for 3 months.
Danish: I den anden undersøgelse fik 149 patienter, som ikke var i dialyse, enten Fexeric eller placebo i 3 måneder.
English: What are the risks associated with Fexeric?
Danish: Hvilke risici er der forbundet med Fexeric?
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that Fexeric's benefits are greater than its risks and recommended that it be approved for use in the EU.
Danish: Agenturets Udvalg for Lægemidler til Mennesker (CHMP) konkluderede, at fordelene ved Fexeric opvejer risiciene, og anbefalede, at det godkendes til anvendelse i EU.
English: The recommended starting dose is 3 to 6 tablets per day, taken in divided doses together with meals.
Danish: Den anbefalede startdosis er 3-6 tabletter dagligt, der tages i flere doser sammen med måltiderne.
English: Blood-phosphate levels should be monitored regularly during treatment.
Danish: Blodets indhold af fosfat bør overvåges regelmæssigt under behandlingen.
English: The most common side effects with Fexeric (which may affect more than 1 in 10 people) are changes in bowel movements (diarrhoea or constipation) and discoloured faeces.
Danish: De hyppigste bivirkninger ved Fexeric (som kan forekomme hos over 1 ud af 10 personer) er ændringer i afføringen (diarré eller forstoppelse) og misfarvet afføring.
English: In addition, the company that markets Fexeric will carry out a study to gain further information on the long-term safety of Fexeric, particularly in older patients.
Danish: Den virksomhed, der markedsfører Fexeric, skal desuden udføre en undersøgelse der skal give flere oplysninger om den langsigtede sikkerhed af Fexeric, navnlig hos ældre.
English: This prevents the phosphate from being absorbed into the body and helps to keep down the phosphate levels in the blood.
Danish: Derved undgås, at fosfatet optages i kroppen, hvilket medvirker til at holdes fosfatindholdet i blodet nede.
English: It is not intended to provide practical advice on how to use Fexeric.
Danish: Det er ikke en praktisk vejledning i, hvordan Fexeric bør anvendes.
English: Patients with severe kidney disease have difficulty eliminating phosphate from their bodies.
Danish: Patienter med svær nyresygdom har vanskeligt ved at udskille fosfat.
English: In the first study, Fexeric was as effective as sevelamer carbonate, an approved medicine, in lowering phosphate levels in 359 patients with long-term kidney disease: after 12 weeks both treatments resulted in a reduction in phosphate levels of around 2 mg/dl.
Danish: I den første undersøgelse var Fexeric lige så effektivt som det godkendte lægemiddel sevelamercarbonat til at sænke fosfatindholdet hos 359 patienter med langvarig nyresygdom: Efter 12 uger resulterede begge behandlinger i en nedsættelse af fosfatindholdet på ca. 2 mg/dl.
English: When taken with meals, the iron contained in Fexeric binds to phosphate from food in the gut, forming a compound that is then eliminated in the stools.
Danish: Når det tages sammen med et måltid, bindes jernindholdet i Fexeric til fosfatet fra føden i tarmen og danner en forbindelse, der derefter udskilles i afføringen.
English: Both studies looked at the change in the amount of phosphate in the blood, measured in mg/dl.
Danish: I begge undersøgelser blev ændringen i blodets fosfatindhold målt i enheden mg/dl.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Fexeric, including the appropriate precautions to be followed by healthcare
Danish: På baggrund af denne er der anført sikkerhedsoplysninger i produktresuméet og indlægssedlen for Fexeric, herunder passende forholdsregler, som sundhedspersonale og patienter skal følge.
English: For more information about treatment with Fexeric, read the package leaflet (also part of the EPAR) or contact
Danish: Hvis du ønsker yderligere oplysninger om behandling med Fexeric, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: Fexeric must not be used in patients with low blood-phosphate levels, patients who have severe problems with the stomach and gut (such as bleeding from the gut), and those with iron accumulation disorders such as haemochromatosis.
Danish: Fexeric må ikke anvendes ved lavt fosfatindhold i blodet, ved alvorlige problemer med maven og tarmen (såsom blødning fra tarmen) eller ved sygdomme, hvor jern ophobes, såsom hæmokromatose.
English: The study showed that blood-phosphate levels fell on average by 0.7 mg/dl with Fexeric compared with 0.3 mg/dl with placebo.
Danish: I undersøgelsen faldt blodets indhold af fosfat gennemsnitligt med 0,7 mg/dl med Fexeric,
English: The active substance in Fexeric, ferric citrate coordination complex, is a phosphate binder.
Danish: Det aktive stof i Fexeric er et koordinationskompleks af ferricitrat, som er en fosfatbinder.
English: What benefits of Fexeric have been shown in studies?
Danish: Hvilke fordele viser undersøgelserne, at der er ved Fexeric?
English: Fexeric was shown to be effective at controlling blood-phosphate levels in 2 main studies in patients with long-term kidney disease and hyperphosphataemia.
Danish: Fexeric blev påvist at være effektivt til at kontrollere blodets indhold af fosfat i to hovedundersøgelser hos patienter med langvarig nyresygdom og hyperfosfatæmi.
English: The CHMP considered that Fexeric is effective at controlling blood-phosphate levels in patients with long-term kidney disease, whether they are on dialysis or not.
Danish: CHMP fandt, at Fexeric er effektivt til at kontrollere blodets indhold af fosfat hos patienter med langvarig nyresygdom, hvad enten de er i dialyse eller ej.
English: Fexeric is a medicine used to control hyperphosphataemia (high levels of phosphate in the blood) in adults with long-term kidney disease.
Danish: Fexeric er et lægemiddel, der anvendes til at kontrollere for højt fosfatindhold i blodet (hyperfosfatæmi) hos voksne med langvarig nyresygdom.
English: A build-up of phosphate leads to hyperphosphataemia and in the long-term can cause complications such as heart
Danish: Ophobning af fosfat medfører for højt fosfatindhold i blodet (hyperfosfatæmi), hvilket i det lange løb kan give komplikationer i form af
English: It contains the active substance ferric citrate coordination
Danish: Det indeholder det aktive stof jerncitrat (ferricitrat) som koordinationskompleks.
English: For practical information about using Fexeric, patients should read the package leaflet or contact their
Danish: Hvis du ønsker praktisk vejledning om anvendelsen af Fexeric, kan du læse indlægssedlen eller
English: Patients should keep to their prescribed low
Danish: Patienten bør overholde den fosfatfattige kost, der er
English: For the full list of all side effects reported with
Danish: Den fuldstændige liste over indberettede bivirkninger ved Fexeric fremgår af indlægssedlen.
English: What is Sliwens?
Danish: Hvad er Sliwens?
English: EMA/23705/2010 EMEA/H/C/1102
Danish: 20. januar 2009 EMA/139264/2010 EMEA/H/C/1102
English: The effects of Sliwens were first tested in experimental models before being studied in humans.
Danish: Virkningerne af Sliwens blev først afprøvet i forsøgsmodeller, inden de blev undersøgt hos mennesker.
English: It was to be available as tablets.
Danish: Det skulle have været leveret som tabletter.
English: What was Sliwens expected to be used for?
Danish: Hvad forventedes Sliwens anvendt til?
English: The main measures of effectiveness were based on the amount of time the patients spent awake after they had first fallen asleep and improvements in the quality of sleep over the first four to 12 weeks of treatment.
Danish: De vigtigste mål for virkningen var baseret på, hvor lang tid patienterne lå vågne, efter at de først var faldet i søvn, samt forbedringer af søvnkvaliteten i løbet af de første fire til 12 uger af behandlingen.
English: Sliwens is a medicine that contains the active substance eplivanserin.
Danish: Sliwens er et lægemiddel, der indeholder det aktive stof eplivanserin.
English: The company presented results of four main studies involving over 3,000 adults who had difficulty staying asleep.
Danish: Virksomheden fremlagde resultater af fire hovedundersøgelser med deltagelse af over 3 000 voksne med søvnproblemer.
English: It was to be used in patients who have difficulty staying asleep.
Danish: Det skulle anvendes til patienter, som har besvær med at sove igennem.
English: There was also a lack of information comparing the long-term use of Sliwens with placebo.
Danish: Der manglede også oplysninger om effekten af langvarig brug af Sliwens sammenlignet med placebo.
English: The active substance in Sliwens, eplivanserin, is a 5-hydroxytryptamine receptor antagonist.
Danish: Det aktive stof i Sliwens, eplivanserin, er en 5-hydroxytryptamin-receptorantagonist.
English: The studies compared Sliwens with placebo (a dummy treatment).
Danish: I undersøgelserne blev Sliwens sammenlignet med placebo (en virkningsløs behandling).
English: Withdrawal of marketing authorisation application for Sliwens (eplivanserin)
Danish: Tilbagetrækning af ansøgningen om markedsføringstilladelse for Sliwens (eplivanserin)
English: The Committee was also concerned about the risk of diverticulitis (inflammation in little sacs or pouches in the intestines) in patients taking the medicine.
Danish: Udvalget havde også betænkeligheder med hensyn til risikoen for diverticulitis (betændelse i små lommer i tarmene) hos patienter, der får medicinen.
English: On 18 December 2009, Sanofi-Aventis officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Sliwens, for use in adults with chronic (long-term) insomnia who have difficulty staying asleep.
Danish: Den 18. december 2009 meddelte Sanofi-Aventis officielt Udvalget for Humanmedicinske Lægemidler (CHMP), at virksomheden ønskede at tilbagetrække sin ansøgning om markedsføringstilladelse for Sliwens til behandling af voksne med kronisk (langvarig) insomni, som har besvær med at sove igennem.
English: The CHMP considered the effect of Sliwens on sleep to be small.
Danish: CHMP fandt, at Sliwens' effekt på søvn var lille.
English: It blocks receptors in the brain called 5-hydroxytryptamine type 2 receptors, which are involved in regulating the daily cycle of being asleep and being awake.
Danish: Det blokerer receptorer i hjernen kaldet 5-hydroxytryptamin type 2-receptorer, som medvirker ved reguleringen af de perioder i døgnet, hvor man er vågen eller sover.
English: study involving 283 adults compared Sliwens with lormetazepam (another medicine used to treat insomnia) looked at how sleepy the patients were the morning after taking Sliwens.
Danish: I den femte undersøgelse med deltagelse af 283 voksne blev Sliwens sammenlignet med lormetazepam (et andet lægemiddel til behandling af insomni), og man så på, hvor søvnige patienterne var om morgenen efter at have taget Sliwens.
English: Based on the review of the data and the company's response to the CHMP list of questions, at the time of the withdrawal, the CHMP had some concerns and was of the provisional opinion that Sliwens could not have been approved.
Danish: På baggrund af gennemgangen af dataene og virksomhedens besvarelse af CHMP's liste med spørgsmål på tidspunktet for tilbagetrækningen af ansøgningen havde CHMP visse betænkeligheder og var af den foreløbige opfattelse, at Sliwens ikke kunne have været godkendt.
English: The company informed the CHMP that there were no consequences for patients in clinical trials or compassionate use, since all ongoing clinical trials have been discontinued.
Danish: Virksomheden har informeret CHMP om, at der ikke er nogen konsekvenser for patienter, som deltager i kliniske undersøgelser eller i programmer for anvendelse med særlig udleveringstilladelse, eftersom alle igangværende kliniske undersøgelser er blevet afbrudt.
English: Withdrawal of marketing authorisation application for Sliwens (eplivanserin) EMA/23705/2010
Danish: Tilbagetrækning af ansøgningen om markedsføringstilladelse for Sliwens (eplivanserin) EMA/139264/2010
English: By blocking these receptors, eplivanserin was expected to modify the sleep-wake cycle, helping people with long-term insomnia to stay asleep.
Danish: Ved at blokere disse receptorer forventedes eplivanserin at ændre disse perioder og således hjælpe personer med langvarig insomni med at sove igennem.
English: Sliwens was expected to be used in adults with long-term insomnia (difficulty sleeping).
Danish: Sliwens forventedes anvendt til voksne med langvarig insomni (søvnbesvær).
English: How was Sliwens expected to work?
Danish: Hvordan forventedes Sliwens at virke?
English: Zeletavská 1525/1
Danish: Želetavská 1525/1
English: VIOSER SA, 9th Km National Highway TrikalaLarissis,
Danish: Grækenland VIOSER SA, 9th Km National Highway TrikalaLarissis,
English: 6th floor, ap 37+Sofia Bulgaria
Danish: 6th floor, ap 37+Sofia
English: B-dul Theodor Pallady nr. 50, sector 3, Bucureşti,
Danish: B-dul Theodor Pallady nr. 50, sector 3,
English: Leskoškova cesta 9D 1000 Ljubljana Slovenia
Danish: Leskoškova cesta 9D 1000 Ljubljana
English: Box 35, Taxiarhes, Trikala,
Danish: P.O. Box 35, Taxiarhes, Trikala
English: B-7860 Lessines Belgium
Danish: B-7860 Lessines
English: UAB “BERLIN CHEMIE MENARINI BALTIC” Jasinskio 16a, LT-01112 Vilnius, Lithuania
Danish: UAB “BERLIN CHEMIE MENARINI BALTIC” Jasinskio 16a, LT-01112 Vilnius,
English: Strada Fânarului nr. 2A, 500464 Braşov, Romania
Danish: Strada Fânarului nr. 2A, 500464 Braşov,
English: HyperHAES 6% in 7,2 % NaClInfusionsloesung
Danish: HyperHAES 6% in 7,2 % NaCl
English: Belgium Baxter SA Bd Rene Branquart, 80 7860 Lessines Belgium
Danish: Bd Rene Branquart, 80 7860 Lessines Belgium
English: Pouet de Camilo, 2 46394 Ribarroja del Turia (Valencia) Spain
Danish: Polígono Industrial Sector 14 ouet de Camilo, 2 46394 Ribarroja del Turia (Valencia) Spain
English: Fresenius Kabi EOOD "Alexander Jendov" str.
Danish: Bulgarien Fresenius Kabi EOOD 1 "Alexander Jendov" str.
English: Medias International d.o.o.
Danish: Slovenien Medias International d.o.o.
English: S.C. Fresenius Kabi Romania S.R.L, strada Fanarului nr. 2A, 500464 Brasov, Romania
Danish: Rumænien S.C. Fresenius Kabi Romania S.R.L, strada Fanarului nr. 2A, 500464 Brasov,
English: Baxter S.p.A. Piazzale dell industria,
Danish: Piazzale dell industria,
English: Voluven 6% Solution for Infusion (Polyolefine/Freefle x Bag
Danish: Voluven 6% Solution for Infusion (Polyolefine/Freeflex Bag
English: S.C. FRESENIUS KABI ROMÂNIA S.R.L.
Danish: Rumænien S.C. FRESENIUS KABI ROMÂNIA S.R.L.
English: S.C. INFOMED FLUIDS S.R.L.,
Danish: Rumænien S.C. INFOMED FLUIDS S.R.L.,
English: S.C. INFOMED FLUIDS S.R.L.
Danish: Rumænien S.C. INFOMED FLUIDS S.R.L.
English: Hydroksyetyloskro bia 200/0,5 Baxter
Danish: Hydroxyethylstivelse 10% Hydroksyetyloskrobia 200/0,5 Baxter
English: 9th Km National Highway Trikal-Larissa, P.O.
Danish: Grækenland VIOSER SA 9th Km National Highway Trikal-Larissa, P.O. Box 35, Taksiarhes Trikalon,
English: Baxter Deutschland GmbH
Danish: Bulgarien Baxter Deutschland GmbH,
English: Poli(O-2-hydroxyethyl) starch
Danish: Poli(O-2hydroxyethyl)-stivelse
English: Poly-(o-2 hydroxyethyl)starch (M.W 200000) + Sodium Chloride
Danish: Poly-(o-2 hydroxyethyl)-stivelse (M.W 200000) + natriumchlorid
English: Serumwerk Bernburg AG
Danish: Serumwerk Bernburg AG Hallesche Landstr.
English: 78310 Maurepas France hydroxyethyl starch 130
Danish: 78310 Maurepas France
English: Baxter d.o.o.
Danish: Slovenien Baxter d.o.o.
English: DK-3450 Allerød Denmark
Danish: Baxter A/S, Gydevang DK-3450 Allerød, Denmark
English: 60 g/l, 72 g/l, water ad 1000 ml
Danish: 60 g/l, 72 g/l, vand ad 1000 ml
English: VIOSER SA
Danish: Bucureşti,
English: 100 g/l, 9 g/l, water ad 1000 ml
Danish: 100 g/l, 9 g/l, vand ad 1000 ml
English: Box 1110 +1120 DE-34209 Melsungen Germany
Danish: B. Braun Melsungen AG P.O. Box 1110 +1120 DE-34209 Melsungen Germany
English: HAES-steril „Fresenius" (HES
Danish: HAES-steril „Fresenius" (HES 200/0,5) 6 %Infusionsloesung
English: 0.450.55 AV. MW 200K, sodium chloride
Danish: substitution 0,45-0,55, natriumchlorid
English: Fresenius Kabi Nederland B.V. Molenberglei 7 2627 Schelle Belgium active substance: hydroxyethyl starch (MR
Danish: Molenberglei 7 2627 Schelle Belgium aktivt stof:
English: 34212 Melsugen
Danish: 34212 Melsungen
English: BAXTER HELLAS Ltd, Metsovou 3, Neo Irakleion 14121, Athens Greece
Danish: Neo Irakleion 14121, Athens
English: 164 94 Kista Sweden hydroxyethyl starch,
Danish: 164 94 Kista Sweden
English: Poly (O-2-hydroxyethyl) starch mol.
Danish: Poly(O-2hydroxyethyl)-stivelse mol.
English: Baxter Deutschland GmbH, Edissonstrasse 4+Unterschleissheim,
Danish: Baxter Deutschland GmbH Edisonstr.
English: United Kingdom poly(o-2hydroxyethyl)starch sodium acetate trihydrate sodium chloride potassium chloride magnesium chloride hexahydrate
Danish: United Kingdom poly(o-2hydroxyethyl)-stivelse natriumacetattrihydrat natriumchlorid kaliumchlorid magnesiumchloridhexa hydrat
English: 69007 Lyon France hydroxyethyl starch 200
Danish: 69007 Lyon France
English: 60 g/l, 9 g/l, water ad 1000 ml
Danish: 60 g/l, 9 g/l, vand ad 1000 ml
English: Poli(O-2-hydroxyethyl) starch, Sodium chloride
Danish: Poli(O-2hydroxyethyl)-stivelse, natriumchlorid
English: United Kingdom poly (o-2hydroxyethyl)starch sodium chloride
Danish: United Kingdom poly (o-2hydroxyethyl)-stivelse natriumchlorid
English: Caxton Way, Thetford, Norfolk IP24 3SE United Kingdom
Danish: Storbritannien Baxter Healthcare Limited, Caxton Way, Thetford, Norfolk IP24
English: 60 g/l, 0,3 g/l, 0,3 g/l, 6,02 g/l, 4,63 g/l, water ad 1000 ml
Danish: 60 g/l, 0,3 g/l, 0,3 g/l, 6,02 g/l, 4,63 g/l, vand ad 1000 ml
English: Hydroxyethyl starch (HES), sodium chloride, water
Danish: Hydroxyethylstivelse (HES), natriumchlorid, vand
English: 0,134 g/l, 60 g/l, 0,4 g/l, 0,2 g/l, 6 g/l, 3,7 g/l, water ad 1000 ml
Danish: 0,134 g/l, 60 g/l, 0,4 g/l, 0,2 g/l, 6 g/l, 3,7 g/l, vand ad 1000 ml
English: Stella-Klein-Loew-Weg
Danish: Baxter Healthcare GmbH Stella-Klein-Loew-Weg
English: B. BRAUN MELSUNGEN AG,
Danish: Rumænien B. BRAUN MELSUNGEN AG,
English: Sodium Chlorid, Hydroxyethyl starch
Danish: Natriumchlorid, hydroxyethylstivelse
English: Poly-(o-2-hydroxyethyl)starch (M.W 200000) + sodium acetate trihydrate + sodium chloride + potassium chloride + magnesium chloride hexahydrate
Danish: Poly-(o-2hydroxyethyl)-stivelse (M.W 200000) + natriumacetattrihydrat + natriumchlorid + kaliumchlorid + magnesiumchloridhexa hydrat
English: Poly(O-2hydoxyethyl)starch 130/0.4, Sodium chloride, Sodium acetate trihydrate, Potassium chloride, Magnesium chloride hexahydrate
Danish: Poly(O-2-hydoxyethyl)stivelse 130/0,4, natriumchlorid, natriumacetattrihydrat, kaliumchlorid, magnesiumchloridhexa hydrat
English: 0,37 g/l, 100 g/l, 0,3 g/l, 0,2 g/l, 6,25 g/l, 3,27 g/l, 0,67 g/l, 1,197 g/l, water ad 1000 ml
Danish: 0,37 g/l, 100 g/l, 0,3 g/l, 0,2 g/l, 6,25 g/l, 3,27 g/l, 0,67 g/l, 1,197 g/l, vand ad 1000 ml
English: 0,37 g/l, 60 g/l, 0,3 g/l, 0,2 g/l, 6,25 g/l, 3,27 g/l, 0,67 g/l, 1,197 g/l, water ad 1000 ml
Danish: 0,37 g/l, 60 g/l, 0,3 g/l, 0,2 g/l, 6,25 g/l, 3,27 g/l, 0,67 g/l, 1,197 g/l, vand ad 1000 ml
English: Haes-Steril 6% 60 mg/ml
Danish: Hydroxyethylstivelse Haes-Steril 6% 60 mg/ml
English: Belgium B. Braun Melsungen AG Carl-Braun-Strasse 1
Danish: Storbritannien B Braun Melsungen AG Carl-Braun-Strasse 1
English: Str.1, D34212 Melsungen, Germany
Danish: D-34212 Melsungen, Germany
English: Poly(O-2-hydroxyethyl) starch (HES), Sodium chloride
Danish: Poly(O-2hydroxyethyl)-stivelse (HES), natriumchlorid
English: HAES - steril 10% 100 g/l
Danish: Hydroxyethylstivelse HAES - steril 10% 100 g/l
English: Hydroxyethy starch, Sodium chloride
Danish: Hydroxyethyl)-stivelse, natriumchlorid
English: Hydroxyethyl Starch
Danish: Hydroxyethylstivelse Stabisol
English: Luxembourg Fresenius Kabi Deutschland GmbH 61346 Bad Homburg v.d.H
Danish: Slovenien Fresenius Kabi Deutschland GmbH 61346 Bad Homburg v.d.H.
English: Haes-Steril 10% 100 mg/ml
Danish: Hydroxyethylstivelse Haes-Steril 10% 100 mg/ml
English: Belgium Fresenius Kabi NV Molenberglei 7
Danish: Fresenius Kabi NV Molenberglei 7 2627 Schelle Belgium
English: B. Braun Melsungen AG (Melsungen) Carl-Braun-Strasse 1 34212 Melsungen Germany active substance: hydroxyethyl starch (MR
Danish: B. Braun Melsungen AG (Melsungen) Carl-Braun-Strasse 1 34212 Melsungen Germany aktivt stof:
English: Sodium chloride, potassium chloride, magnesium chloride hexahydrate, sodium acetate trihydrate, malic acid, poly (0-2hydroxyethyl) starch, calcium chloride dihydrate
Danish: Natriumchlorid, kaliumchlorid, magnesiumchloridhexa hydrat, natriumacetattrihydrat, æblesyre, poly(0-2hydroxyethyl)-stivelse, calciumchloriddihydrat
English: Poli(0-2hydroxyethyl)starch(HEK) , Sodium chloride, Potassium chloride, Calcium chloride dihydrate, Magnesium chloride heksahydrate, Sodium acetate trihydrate, Malic acid
Danish: Poli(0-2-hydroxyethyl)stivelse(HEK), natriumchlorid, kaliumchlorid, calciumchloriddihydrat, magnesiumchloridhexa hydrat, natriumacetattrihydrat, æblesyre
English: VENOFUNDIN 60.0 g/l, 9 g/l
Danish: 60,0 g/, 9,0 g/l
English: 60 g/l
Danish: INFOHES 60 g/L
English: Sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate,sodium acetate trihydrate, malic acid, poly (0-2hydroxyethyl) starch
Danish: Natriumchlorid, kaliumchlorid, calciumchloriddihydrat, magnesiumchloridhexa hydrat, natriumacetattrihydrat, æblesyre, poly(0-2hydroxyethyl)-stivelse